# Safety and Efficacy of Longterm HPN With Two Lipid Emulsions

> **NCT00530738** · PHASE4 · COMPLETED · sponsor: **B. Braun Melsungen AG** · enrollment: 42 (actual)

## Conditions studied

- Malnutrition

## Interventions

- **DRUG:** Lipoplus
- **DRUG:** Lipofundin MCT

## Key facts

- **NCT ID:** NCT00530738
- **Lead sponsor:** B. Braun Melsungen AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530738, "Safety and Efficacy of Longterm HPN With Two Lipid Emulsions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00530738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*